MXPA97006412A - Use of inorganic aerogels in the farmaceut industry - Google Patents
Use of inorganic aerogels in the farmaceut industryInfo
- Publication number
- MXPA97006412A MXPA97006412A MXPA/A/1997/006412A MX9706412A MXPA97006412A MX PA97006412 A MXPA97006412 A MX PA97006412A MX 9706412 A MX9706412 A MX 9706412A MX PA97006412 A MXPA97006412 A MX PA97006412A
- Authority
- MX
- Mexico
- Prior art keywords
- aerogels
- airgel
- hydrophilic
- hydrophobic
- pharmaceutical
- Prior art date
Links
- 239000004964 aerogel Substances 0.000 title claims abstract description 60
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 5
- 230000005661 hydrophobic surface Effects 0.000 claims description 3
- 210000004051 Gastric Juice Anatomy 0.000 claims description 2
- 230000003111 delayed Effects 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000000546 pharmaceutic aid Substances 0.000 claims description 2
- 230000002500 effect on skin Effects 0.000 claims 1
- 230000000699 topical Effects 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000002209 hydrophobic Effects 0.000 description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000000499 gel Substances 0.000 description 22
- 238000011068 load Methods 0.000 description 17
- 239000000126 substance Substances 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000001035 drying Methods 0.000 description 11
- 239000000843 powder Substances 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 239000002609 media Substances 0.000 description 9
- 239000000829 suppository Substances 0.000 description 8
- YPXOPAFVVHXQDP-UHFFFAOYSA-N 1-[(2,4-dimethylphenyl)hydrazinylidene]naphthalen-2-one Chemical compound CC1=CC(C)=CC=C1NN=C1C2=CC=CC=C2C=CC1=O YPXOPAFVVHXQDP-UHFFFAOYSA-N 0.000 description 7
- 229910052681 coesite Inorganic materials 0.000 description 7
- 229910052906 cristobalite Inorganic materials 0.000 description 7
- 229910052904 quartz Inorganic materials 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 229910052682 stishovite Inorganic materials 0.000 description 7
- 229940073450 sudan red Drugs 0.000 description 7
- 229910052905 tridymite Inorganic materials 0.000 description 7
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 206010001497 Agitation Diseases 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N Furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 101710036359 UL47 Proteins 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 229960003883 Furosemide Drugs 0.000 description 3
- VHRSUDSXCMQTMA-PJHHCJLFSA-N Methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229960004584 methylprednisolone Drugs 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000008159 sesame oil Substances 0.000 description 3
- 235000011803 sesame oil Nutrition 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- OIGNJSKKLXVSLS-VWUMJDOOSA-N Prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000002612 dispersion media Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007970 homogeneous dispersion Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 238000005020 pharmaceutical industry Methods 0.000 description 2
- 229960005205 prednisolone Drugs 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000002511 suppository base Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N Carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229960001484 Edetic Acid Drugs 0.000 description 1
- 229960002143 Fluorescein Drugs 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- OQAPLBZOHJKLII-UHFFFAOYSA-N O.O.[Na].[Na].[Na].[Na] Chemical compound O.O.[Na].[Na].[Na].[Na] OQAPLBZOHJKLII-UHFFFAOYSA-N 0.000 description 1
- 229940099511 POLYSORBATE 65 Drugs 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002642 Polysorbate 65 Polymers 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N Propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N Sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940020947 fluorescein sodium Drugs 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000004301 light adaptation Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N silicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 238000000352 supercritical drying Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 235000010215 titanium dioxide Nutrition 0.000 description 1
- 239000011240 wet gel Substances 0.000 description 1
Abstract
The invention relates to the use of inorganic aerogels as auxiliary material and / or vehicle for active ingredients and / or pharmaceutical preparations.
Description
USE OF INORGANIC AERQGELS IN THE PHARMACEUTICAL INDUSTRY
DESCRIPTIVE MEMORY
This invention relates to the use of inorganic aerogels as auxiliaries and / or excipients for compounds and / or active pharmaceutical preparations. Aerogels, in particular those having porosities of more than 60% and densities below 0.6 g / cm 3, have an extremely low thermal conductivity and are therefore used as an insulating material to heat as described, for example, in EP-A-0 171 722. Moreover, the. use of aerogels for Cerenkov detectors based on their refractive index, which is very low for solids. In addition, thanks to the particular acoustic impedance of the aerogels, a possible use as a means of adaptation impedance is described in the literature, for example in the ultrasonic field. Aerogels in the broadest sense, that is, in the sense of "gel with air as a dispersant", are prepared by drying a suitable gel. The term "airgel" in this sense includes aerogels in the narrowest sense, xerogeneous and cryogenic. A dry gel is designated co or an airgel in the narrowest sense here if the gel liquid is removed to the greatest extent possible at temperatures above the critical temperature and starting from pressures above the critical pressure. However, if the gel liquid is removed subcitically, for example with the formation of a liquid / vapor limit phase, then the resulting gel is designated co or xerogel. When the term aerogels is used in the present application, it is aerogels in the broadest sense, that is, in the sense of "gel with air as a dispersant". In addition, aerogels can be subdivided basically into inorganic and organic aerogels. Inorganic aerogels have been known since 1931 (S.S. Kistler, Nature 1931, 127, 741). Since then, aerogels have been prepared to par + go of all kinds of starting materials. It was possible to prepare, for example, aerogels S1O2, AI2O3, T ?? 2 ZrÜ2, Sn? 2 L12O, Ce? 2 and V2O5, so Corno mixtures thereof (HD Gesser, PC Goswami, Chem. Rev. 1989, 89, 756 f). For some years, organic aerogels made from all kinds of starting materials have also been known, such as, for example, from rnelamma forrnaldehyde (RU Pekala, 3. Mater, Sci. 1989, 24, 3221 ). Aerogels can be prepared here in all kinds of different ways. For example,? 1O2 aerogels can be prepared by the acid hydrolysis and condensation of orthosilicate tetraethyl in ethanol. In this process, a gel is obtained which can be dried with the retention of the structure by means of surface drying. Preparation methods based on this drying technique are known, for example, from EP-A-0 396 076 or UO 92/03378. An alternative is offered as a procedure for the subcritical drying of S1O2 gels if they are reacted with a silylating agent containing chlorine before drying. The S1O2 gel can be obtained here, for example, by the acid hydrolysis of tet ralcoxysLlanos in a suitable organic solvent by means of water. After replacing the solvent with a suitable organic solvent, the gel obtained is reacted in an additional step with a silylating agent. The resulting S1O2 gel can be dried posteriorly in the air that comes from an organic solvent. In this way aerogels can be obtained with densities of less than 0.4 g / cm3 and porosities of 60% rnáe. The preparation process based on this drying technique is described in detail in UO 94/25149. The gels described above can be further treated with ralycoxysilane and be aged before being dried in the aqueous alcoholic solution to increase the network strength of the gel, e.g., as described in UO 92/20623. Moreover, the S1O2 gel can also be prepared on the basis of a water glass. The preparation process based on this technique is known from DE-A-43 42 548. German patent application 19502453.2 further describes the use of chlorine-free silliating agents. The aerogels obtained by supercritical drying are, depending on the procedure used specifically, hydrophilic or, in the short term, hydrophobic. In the long term, however, they are hydrophilic. This can be avoided by a hydrophobicizing step during suporcritical drying. Such a process is known from EP-A-0 396 076. Due to its preparation process, (silylated before drying), the dried aerogels are essentially hydrophobic. The use of colloidal silica in therapeutic copper compositions is known, for example, from US-A-4,123.51l. In the same way, the use of organic aerogels in medicine is known (UO 95/01165). It is an object of the present invention to search for novel applications for aerogels. It has now surprisingly been found that inorganic aerogels are suitable as an auxiliary and / or excipient for the active compounds and / or pharmaceutical preparations. It should be understood in the present invention that an inorganic airgel means an airgel that has been prepared based on inorganic materials. The term "aerogels based on inorganic materials" also includes in particular those aerogels that have been modified, for example by sil ila tion. Aerogels comprising mainly S1O2, AI2O3, TiO2, Zr2, or mixtures thereof are preferred.
Depending on the use they may have hydrophilic and / or hydrophobic surface groups (e.g., OH, OR, R). The preparation of aerogels having hydrophilic and / or hydrophobic surface groups can be carried out here by all methods known to the person skilled in the art, particularly aerogels containing hydrophilic and / or hydrophobic S1O2, in particular. The agents of 102. Moreover, it has been surprisingly discovered that by choosing a suitable hydrophilic and / or hydrophobic airgel, suitable substances can be released with which the airgel has been loaded in an accelerated or delayed manner. used as dispersants for dispersions of solid, liquid or gaseous substances in liquid or solid media, Moreover, hydrophilic and / or hydrophobic aerogels loaded with hydrophilic and / or hydrophobic substances can be incorporated without problems in hydrophilic and / or hydrophobic media, liquid , semi-solid or solid, in particular in order, with the help of aerogels hydrophilic, for introducing hydrophobic (ie, lipophilic) substances into liquid hydrophilic dispersion media and / or isolids, and with the aid of hydrophobic aerogels to introduce hydrophilic substances into liquid hydrophobic dispersion media. Hydrophobic aerogels, for example, float on hydrophilic aqueous media by means of which pharmaceutical excipient systems floating on the gastric juice are possible. In addition, it is also possible to convert hydrophilic or hydrophobic liquid substances into free flowing solid powders or granules. Problem-free processing, for example, giving tablets, capsules or suppositories is thus possible. In addition with suitable aerogels, it is also possible to prepare lotions, creams and gels with and without a peeling effect. Substances within the meaning of these applications are substances that can be used in the pharmaceutical industry, eg, pharmaceutical products, aromatic substances and flavors. The invention is described in greater detail in the following, with the help of working examples, if to be restricted by these.
EXAMPLES OF PREPORTION
EXAMPLE 1
Preparation of a permanently hydrophobic 1% aerogel of a soda glass beaker solution (containing 7% by weight of SiO 2 and a Na 2: 2 ratio of 1: 3.3) was stirred together with 0.5 1 an acid ion exchange resin (styrene-divimlbenzene copolymer with sulfonic acid groups, available commercially under the name RDuolite C20), until the pH of the aqueous solution was 2.3. The ion exchange resin was subsequently removed by filtration and the aqueous solution was adjusted to a pH of 5.0 using a 1 molar solution of NaOH. The resulting gel was subsequently aged at 85 ° C for 3 more hours and the water was subsequently replaced by acetone using 3 1 of acetone. The gel containing acetone was subsequently silylated with tp ethiichlorosilane (5% by weight of tprnethylchlorosilane per gram of wet gel). The gel was dried in air (3 hours at 40 ° C, then 2 hours at 50 ° C and 12 hours at 150 ° C). The transparent airgel thus obtained had a density of 0.15 g / cm3, its specific surface according to BET was 480 rn2 / g and was permanently hydrophobic.
EXAMPLE 2
Preparation of a hydrophilic airgel The permanently hydrophobic airgel prepared in example 1 was pyrolyzed for 1 hour at 600 ° C in a gentle stream of air by means of a tube furnace. The transparent airgel obtained had a density of 0.18 g / cm 3, a specific surface area according to BET of 450 m2 / g and was hydrophilic.
EXAMPLES OF USE
In the use examples, hydrophilic and hydrophobic aerogels such as those obtained according to the preparation examples 1 and 2 are used.
EXAMPLE 1
Humidity of aerogels
Ae og l Hydrophobic Hydrophilic
Acetone + + Ethanol + + Ethyl acetate + + n-Hexane + + Methanol + + i-Propanol + + Water +
+: humectant; -: no humectant
EXAMPLE 2
Water absorption of aerogeleß during intensive mechanical incorporation
Water absorption (%) Description Hydrophilic airgel up to 240 free flowing powder 280 gelatinous consistency 300 highly liquid suspension Hydrophobic airgel up to 140 free flowing powder 260 viscous paste 320 suspension bl nca vi scosa
EXAMPLE 3
Loading of aerogels with carboxyfluorescein of Na 5 g of airgel are treated with 50 ml of a solution of carboxyfluorescein of ethanolic Na of 1.5% strength and the mixture is stirred for 2 hours. After filtration, the residue is dried at room temperature under normal pressure and the product is sieved. A free-flowing powder is obtained.
Content of carboxyfluorescein of Na Hydrophilic airgel 6.2% Hydrophobic airgel 5.7% í.e. at least 38% of the amount of substance added is absorbed.
EXAMPLE 4
Release of Na carboxyfluorescein by aerogels
Release device: Palette (USP) Medium: Water, 37 ° C
Release time (rnin) 5 60 150 Hydrophilic airgel 51% 80% n.d Aerobic hi rofóbico 13 18% 38%
EXAMPLE 5
Loading of aerogels with active pharmaceutical compounds Loading by suspension of the excipient (hydrophilic / hydrophobic airgel) in an active compound solution and the subsequent drying (normal pressure or reduced pressure) or the application of an active compound solution to the dry excipient and the subsequent subsequent drying. You get free flowing powder. A) Initially introduce 1 g of airgel, add 20 ml of a fluoroose ida solution of 5% strength (acetone) with stirring, allow the solvent to evaporate under normal pressure and at room temperature. Loading of active compound: 50% B) Initially introduce 1 g of airgel, add 2 ml of a fluoroose ida solution of 5% strength (acetone) with stirring, allow the solvent to evaporate under normal pressure and at room temperature repeat until the desired load (eg, four times) Active compound loading: 33.3% C) Impartially introduce 1 g of airgel, add a fluoroseride solution of 5% strength (acetone) to obtain a powder still flowable, drying later (normal pressure or reduced pressure) Active compound loading: 13.0% D) Initially introduce 1 g of airgel, add 15 rnl of a solution of fluorosemide-sodium of 1.3% strength (acetone) with agitation, allow the solvent to evaporate at normal pressure and at room temperature Active compound loading: 33.3% E) Initially introduce 1 g of airgel, add 15 i of a solution of penbutulol hernisulfate of 1.3% strength (ethanol / ethanol 1: 1) with agit ation, allow the solvent to evaporate at normal pressure and at room temperature Active compound load: 16.6% F) Initially introduce 1 g of airgel, add 20 ml of a solution of HOE 277 * of 1% strength (ethanol) with stirring , allow the solvent to evaporate at normal pressure and at room temperature 1?
Loading of active compound: 16.6% * N, N- (3-rnetox? Pro? L) acid arc p? R? D? No-2,4-d? CarhoxLl ico
(described in EP-A-0 409 119). G) Introduce micivalent 1 g of airgel, add 13.5 ml of a methylprednisolone solution of 0.7r > % Resistance (ethanol) with stirring, allow the solvent to evaporate at normal pressure and at room temperature Active compound loading: 9.1%
EXAMPLE 6
Release of active pharmaceutical compounds from aerogels
A) Release of netilprednisolone from hydrophobic airgel
Loading: 9.1% methylprednisolone Release method: blade agitator method GP10 Medium: hydrochloric acid at 0.1 N
Time (min) Release of substance Release of pure prednisolone (%) prednisolone from hydrophobic airgel (%) 15 18.8 16.8 120 84.1 41.1 480 91.5 58.7 1440 92.3 77.2
B) Release of rnetilprednisolone from aerogels
Load: 9.1% methylprednisolone
Release method: GP10 blade agitator method Medium: pH 7.5 phosphate buffer
Time (min) Liberation Release Release of pure substance methylprednisomet ilpredni- (%) canvas from solon to airgel par-t r hydrophilic airgel hi- (%) drofo ico (%)
3 3.9 56.5 1.6 6 12.5 68.2 3.1 15 33.2 75.3 6.5 30 53.9 78.6 11.6
C) Release of Hoe 277 from aerogels
Loading: 16.6% Hoe 277 Release method: GP10 blade agitator method Medium: hydrochloric acid at 0.1 N Time (rnin) Release of Hoe 277 Liberac: in from from airgel Hoe 277 to hydrophilic (%) pa rt Lr * ele a ro * hydrophobic gel (%) 6 94.3 20 .8 15 94.3 24 .9
30 94.8 28.9 D) Release of furosemide from aerogels
Loading: 50% furosemide Release method: agitator method
blade GP10 Medium: water
Time (in) Release of substance Release of pure furose ida (%) furosemide to
part of hydrophilic airgel (%) 3 8.7 2.3
OE¡ 6 15.7 2.7 15 29.9 5.5 30 49.5 9.0 EXAMPLE 7
Preparation of airgel tablets
Recipe: Microcrystalline cellulose 1 part Corn starch 1 part Mg stearate 0.01 parts Aerogé1 * 0.05 parts
*: Aerogels containing carboxyfluorescein of Na of Example 3 (hydrophilic or hydrophobic) Procedure: mixing of the components and subsequent direct tapping using an eccentric tablet press to give round biplane tablets (0 6 mm) with a mass of 100 mg and a radial compression resistance of 50 and 100 N. Tablets can be prepared without problems using hydrophilic and hydrophobic aerogels
EXAMPLE 8
Preparation of airgel capsules
Recipe: Airgel 2 parts Lactose 1 H2O D 80 ** 98 parts *: Aerogelee containing carboxifluoreecein of Na from example 3 (hydrophilic or hydrophobic) **: Meggle, Uasserburg Procedure: manual filling Free-flowing powders are obtained with both hydrophilic aerogels as with hydrophobic, which can be filled in capsules without problems.
EXAMPLE 9 (a, b, c and d)
Preparation of hydrophilic or hydrophobic airgel suppositories
Recipe: Airgel * 2 parts Lactose I H2O D 8O ** 98 parts *: Aerogels containing carboxyfluorescein of Na from example 3 (hydrophilic (a, b) or hydrophobic (c, d) **: Uitepsol H 12 (a, c ) or Uitepsol U 45 (b, d), HÜls, AG, Uitten Procedure: melt molding process Hydrophilic and hydrophobic aerogels can be easily incorporated into the two suppository bases.
EXAMPLE 10 (a, b, c and d)
Preparation of airgel suppositories containing water
Recipe: Airgel * 1 part Sol. Fluorescein sodium 1.5% strength 1 part Uitepsol ** 98 parts
*: Aerogels (hydrophilic (a, b) or hydrophobic (c, d) **: Uitepsol H 12 (a, c) or Uitepsol U 45 (b, d), Hüls, AG, Uitten Procedure: molding procedure Fusion The aqueous phase can be incorporated without problems into the two suppository bases.
EXAMPLE 11
Preparation of an airgel lotion
Recipe: Airgel 4.41 g Propylene Glycol 8.82 g
Polysorbate 60 4.41 g
Polysorbate 65 4.41 g
Liquid paraffin, highly liquid 13.24 g
Polyacrylic acid 0.22 g Solution at 1 N of sodium hydroxide 0.88 g
Edetic acid, tetrasodium salt dihydrate 0.09 g
Methyl 4-hydroxybenzoate 0.10 g Propyl -Hydroxybenzoate 0.01 g
Water 63.41 g
Both with the hydrophilic and hydrophobic airgel a white homogenous milk is obtained with a peeling effect.
EXAMPLE 12 (a and b)
Preparation of gels containing airgel
Recipe: Airgel * i1.0 g Miglylol 812 99.0 g
*: Aerogels (hydrophilic) (a) or hydrophobic (b) Clear or slightly opalescent gels are obtained with a peeling effect.
EXAMPLE 13
Loading of hydrophilic or hydrophobic airgel with lipophilic substances
Recipe: Oerogel * 3 g Sudan Red 0.5 g Isopropanol 80 g
Sudan red is dissolved in isopropanol and stirred with the appropriate airgel for 2 hours. After separating the excess, liquid phase, the airgel is dried at room temperature and normal pressure. A free-flowing powder containing Sudan red is obtained.
A) Hydrophilic airgel with Sudan red 1 part Water 99 parts
A homogeneous red suspension is obtained. The agglomeration of particles is not observed.
B) (Comparison example) Sudan red 0.1 parts
Water 99 parts
Even after intense agitation, the dispersal or dispersion of Sudan red in water does not take place. The product agglomerates strongly.
O Hydrophobic airgel with Sudan red 1 part Water 99 parts A homogeneous dispersion of the airgel containing Sudan red on the surface of the water is obtained without the occurrence of agglomerates.
EXAMPLE 15
Loading of airgel with hydrophilic substances
hydrophobic hydrophilic
Recipe: Airgel 1 part 1 part Water 1.4 parts 2 parts Water content (%) 58 66 IDafter intensive crushing, a homogenous free-flowing powder is obtained.
EXAMPLE 16? > Dispersion of hydrophilic substances in hydrophobic media
A) Airgel (containing water) 1 part (hydrophilic or hydrophobic) 0 Sesame oil 50 parts
A homogeneous suspension containing water with gentle agitation is obtained. Water separation can not be observed even after 24 hours.
B) Water 0.1 part Sesame oil 50 parts
Even with vigorous agitation, the homogeneous dispersion of. water (hydrophilic model substance) in sesame oil is not possible. After a short time, droplets of water or dispersed are added. There is always a clear phase separation.
EXAMPLE 17
Preparation of hydrophilic airgel suppositories with a hydrophilic phase 5 included
Recipe: Hydrophilic airgel 1 part Sol. of fluorescein of Na 2 pairs of 1.5% of resistance After the crushing, a powder of free flow is obtained that can be incorporated until a proportion of 33% (= 22% of hydrophilic phase) without problems and homogeneously in bases for suppository melted (Uitepsol H 12 or U 45). No hydrophilic phase of the suppositories escapes. The suppositories of
Uitepsol H 12 with 5% sodium fluorescein solution (1.5% strength) are, however, homogeneous. The hydrophilic phase escapes suppositories.
Claims (9)
1. - EJ use of modified surface inorganic aerogels as an auxiliary and / or excipient for active pharmaceutical compounds and / or compositions.
2. The use according to claim 1, wherein the modified surface aerogels have hydrophobic surface groups,
3. The use of aerogels according to claim 1 or 2 as pharmaceutical auxiliaries for solid oral preparations, semi-solid and / or liquid.
4. The use of aerogels according to claim 1 or 2 as pharmaceutical auxiliaries for topical preparations.
5. The use of aerogels according to claim 4 for preparations for dermal, vaginal, rectal and oral administration.
6. The use of aerogels according to claim 1 or 2 as a pharmaceutical excipient for the accelerated, controlled and / or delayed release of pharmaceutical products.
7. The use of aerogels according to claim 6 for pharmaceutical forms that float in the gastric juice.
8. The use of aerogels according to claim 6 or 7 for the processing of liquid pharmaceutical products.
9. The use of aerogels according to at least one of the preceding claims, which comprises using airgel particles having porosities of more than 60% and densities of less than 0.6 g / cm3.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19506141.1 | 1995-02-22 | ||
DE19506141A DE19506141A1 (en) | 1995-02-22 | 1995-02-22 | Use of aerogels in pharmacy, cosmetics and crop protection |
DE19506141.1 | 1995-02-22 | ||
PCT/EP1996/000731 WO1996025950A1 (en) | 1995-02-22 | 1996-02-22 | Use of inorganic aerogels in pharmacy |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9706412A MX9706412A (en) | 1997-11-29 |
MXPA97006412A true MXPA97006412A (en) | 1998-07-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6280744B1 (en) | Use of inorganic aerogels in pharmacy | |
US4835187A (en) | Spray dried ibuprofen | |
JP4129995B2 (en) | Pharmaceutical composition for rapid suspension in an aqueous medium | |
AU610556B2 (en) | Cholestyramine composition and process for its preparation | |
US4659388A (en) | Additive composition for foods or drugs | |
CA1042307A (en) | Stable suspension system for microencapsulated flowable formulations | |
US4671823A (en) | Sucrose encrusted methyl cellulose particles for use in bulk laxative compositions | |
US8895141B2 (en) | Excipient for compressed tablets comprising novel spherical mannitol | |
US20100068294A1 (en) | Method for Preparing Ortho Silicic Acid, Ortho Silicic Acid as Obtained, and its Use | |
NO312224B1 (en) | Methods for Preparing Pharmaceutical Granules and Pharmaceutical Formulations for Use in Treating Bacterial Infections | |
WO2005117844A2 (en) | Mucoadhesive nanocomposite delivery system | |
US4771077A (en) | Spray dried acetaminophen | |
MXPA97006412A (en) | Use of inorganic aerogels in the farmaceut industry | |
RU2004103853A (en) | GRANULATES CONTAINING FAT-SOLUBLE SUBSTANCES AND METHOD FOR PRODUCING THEM | |
AU751582B2 (en) | Use of inorganic aerogels in pharmacy | |
US5364647A (en) | Powdered preparations of surface active alkylglycosides | |
US20030124242A1 (en) | Capsule comprising at least mineral coating consisting of a single chemical compound and a core comprising at least a polyhydroxylated compound | |
KR100264547B1 (en) | Molten granulated sucralfate preparation and process for producing the same | |
EP0143576A1 (en) | An antacid composition and a process for the preparation thereof | |
WO2008131506A1 (en) | Mucoadhesive granules containing chitosan nano- and/or microspheres and the process of manufacture | |
US6048552A (en) | DASC compositions, process for preparing same and suspensions containing same | |
WO1990004980A1 (en) | Drug composition | |
JP3281002B2 (en) | Sucralfate aqueous suspension stock solution and process for producing the same | |
WO2003099256A3 (en) | FREE-FLOWING, POWDERY COMPOSITION CONTAINING α-LIPONIC ACID (DERIVATIVES) | |
MXPA97006411A (en) | Use of hydrogels in agriculture |